How to Reconstitute a 15 mg Tirzepatide Vial: A Step-by-Step Guide With a Full Dose Chart

Direct answer (40-60 words)

For a 15 mg lyophilized tirzepatide vial, the most common reconstitution is 1.5 mL of bacteriostatic water, which yields a 10 mg/mL solution. At that concentration, 2.5 mg equals 25 units on a U-100 insulin syringe, 5 mg equals 50 units, 7.5 mg equals 75 units, and so on. Always confirm with your pharmacy's specific instructions.

Table of contents

1. The 30-second answer
2. What "reconstitution" means and why a 15 mg vial arrives as powder
3. Equipment checklist before you start
4. The volume question: how much bacteriostatic water for a 15 mg vial
5. Step-by-step reconstitution protocol
6. Dose chart for 15 mg vials at the three common concentrations
7. Drawing the dose with a U-100 insulin syringe
8. Storage, shelf life, and travel
9. Common mistakes and how to spot them
10. When to discard a vial
11. FAQ
12. Footer disclaimers

What "reconstitution" means and why a 15 mg vial arrives as powder

Tirzepatide is a peptide. Like most peptides, it's chemically unstable in liquid solution at room temperature. To extend shelf life and survive shipping, compounding pharmacies often dispense it as a freeze-dried (lyophilized) powder sealed under vacuum or nitrogen in a small glass vial. The patient or pharmacy adds sterile diluent at the point of use to create a liquid you can draw into a syringe.

The diluent of choice is bacteriostatic water for injection, which is sterile water with 0.9% benzyl alcohol added. The benzyl alcohol prevents bacterial growth in the vial after the rubber stopper is punctured. This matters because a multi-dose vial sits in your refrigerator for up to 28 days, and you'll puncture the stopper repeatedly to draw weekly doses.

Sterile water for injection (without preservative) is the alternative. It's used when a patient is allergic to benzyl alcohol, or when the pharmacy's protocol calls for it. Sterile-water-reconstituted vials have a shorter shelf life, typically 7 to 14 days under refrigeration.

A 15 mg vial means 15 milligrams of total tirzepatide powder. The amount of bacteriostatic water you add determines the final concentration (mg/mL), and the concentration determines how many units you draw on a U-100 insulin syringe to get a given dose.

Equipment checklist before you start

Have everything ready before opening anything. The full setup:

• 15 mg lyophilized tirzepatide vial (powder, sealed)
• Bacteriostatic water vial (typically a 30 mL multi-dose vial)
• 3 mL or 5 mL syringe with an 18-gauge or 21-gauge drawing needle (for transferring water into the powder vial)
• U-100 insulin syringes for weekly dosing (0.3 mL or 0.5 mL barrel, 31-gauge, 5/16-inch needle)
• Two alcohol prep pads per reconstitution
• Sharps container
• A clean, flat work surface
• Gloves are optional but reduce contamination risk

Skipping the larger drawing syringe is a mistake. Trying to transfer 1.5 mL of bacteriostatic water using a U-100 insulin syringe means 150 units worth of pulls on a 30-unit-or-50-unit barrel, which takes forever and increases contamination risk. Use a 3 mL syringe for the one-time water transfer.

The volume question: how much bacteriostatic water for a 15 mg vial

Three concentrations are commonly used for 15 mg vials. The amount of bacteriostatic water determines which.

Bacteriostatic water added	Final concentration	Used when
1.5 mL	10 mg/mL	Default for most pharmacies; clean unit math
0.75 mL	20 mg/mL	When low injection volume is preferred
3 mL	5 mg/mL	When low concentration and larger draw volume is preferred (rare)

The most common is 1.5 mL of bacteriostatic water, which makes a 10 mg/mL solution. This is the default because the unit math is clean: 1 mg of tirzepatide equals 0.1 mL equals 10 units on a U-100 insulin syringe. A 2.5 mg dose is 25 units, a 5 mg dose is 50 units, a 7.5 mg dose is 75 units, and so on.

The instruction sheet from your specific pharmacy is the authoritative source. If the sheet says 2 mL, add 2 mL. If it says 1.5 mL, add 1.5 mL. Don't substitute volumes based on a guide, including this one. Different pharmacies use different concentrations to match their dosing protocols.

If you can't find the instruction sheet and you've already opened the box, call the pharmacy before reconstituting. Reconstituting at the wrong volume changes the dose unit math and creates real risk of under- or over-dosing for the next four weeks.

Step-by-step reconstitution protocol

The protocol below assumes you're using 1.5 mL of bacteriostatic water for a 15 mg vial, the most common configuration. Adjust the water volume only based on your pharmacy's instructions.

Step 1: Wash your hands. Soap and water for 20 seconds. Dry with a clean paper towel. Move to a clean, dry work surface.

Step 2: Inspect both vials. Check the powder vial for a uniform white-to-off-white cake at the bottom. The vial should be sealed with an intact aluminum cap and rubber stopper. Check the bacteriostatic water vial for clarity. Discard either if you see particulate matter, cloudiness, cracks in the glass, or a damaged seal.

Step 3: Remove the plastic flip caps. Both vials have a colored plastic flip-top covering the rubber stopper. Pop the flip-tops off with your thumb. The aluminum collar stays in place.

Step 4: Wipe both rubber stoppers with separate alcohol prep pads. Let them air-dry for about 10 seconds. Don't blow on them.

Step 5: Draw 1.5 mL of bacteriostatic water into a 3 mL syringe with an 18- or 21-gauge needle. Pull back the plunger to 1.5 mL of air first, push that air into the bacteriostatic water vial (this prevents a vacuum), then invert the vial and slowly draw 1.5 mL of water. Tap the syringe to dislodge bubbles, push them back, and re-confirm 1.5 mL.

Step 6: Insert the needle into the powder vial at a slight angle. Aim the needle tip against the inner wall of the vial, not directly at the powder cake. Slowly inject the water, letting it run down the inside wall. This minimizes foaming, which can degrade the peptide.

Step 7: Withdraw the needle. The vial now contains 15 mg of powder dissolving in 1.5 mL of water. Don't shake.

Step 8: Swirl gently. Hold the vial by the cap and rotate it in a slow circle for 30 to 60 seconds. The powder should dissolve completely, leaving a clear, colorless to faintly straw-yellow solution. If powder remains, set the vial down for 5 minutes and swirl again. Don't shake hard. Vigorous shaking creates foam and can denature the peptide.

Step 9: Inspect the final solution. It should be clear with no visible particles. If it's cloudy, has visible particles, or looks discolored, call the pharmacy.

Step 10: Label the vial. Write the date of reconstitution on the cap or directly on the label with a permanent marker. The 28-day clock starts now.

Step 11: Refrigerate. Store between 36 and 46 degrees Fahrenheit (2 to 8 degrees Celsius). Don't freeze.

The whole process takes about 5 minutes once you've done it once.

Dose chart for 15 mg vials at the three common concentrations

If your pharmacy used 1.5 mL of bacteriostatic water (10 mg/mL), use the middle column. If 0.75 mL (20 mg/mL), use the right column. If 3 mL (5 mg/mL), use the left column.

Weekly dose	5 mg/mL (3 mL water)	10 mg/mL (1.5 mL water)	20 mg/mL (0.75 mL water)
2.5 mg	50 units	25 units	12.5 units
5 mg	100 units	50 units	25 units
7.5 mg	150 units	75 units	37.5 units
10 mg	200 units	100 units	50 units
12.5 mg	250 units	125 units	62.5 units
15 mg	300 units	150 units	75 units

A 15 mg vial reconstituted to 10 mg/mL gives you exactly 6 doses of 2.5 mg, or 3 doses of 5 mg, or 2 doses of 7.5 mg, or one full 15 mg dose. Plan vial usage around your prescribed weekly dose.

For more on the unit conversion math at every common concentration, see our related guide guide.

Drawing the dose with a U-100 insulin syringe

Once the vial is reconstituted and labeled, weekly dose draws follow this routine:

1. Remove the vial from the refrigerator about 15 minutes before injection. Cold tirzepatide stings more on injection.
2. Wash your hands.
3. Wipe the rubber stopper with an alcohol prep pad and let it air-dry.
4. Pull air into the U-100 insulin syringe equal to the unit count of your dose (for 25 units, pull back to 25; for 50 units, pull to 50). Insert the needle and push the air into the vial. This equalizes pressure.
5. Invert the vial with the needle still inserted. Pull the plunger back past your dose, then push back to your exact dose mark.
6. Tap the syringe to release bubbles. Push bubbles back into the vial. Re-confirm the dose at eye level. The leading edge of the rubber plunger tip (not the trailing edge) should sit on the dose line.
7. Withdraw the needle from the vial. Don't recap.
8. Choose an injection site: abdomen (avoid 2 inches around the navel), front or outer thigh, or back of upper arm. Rotate sites weekly.
9. Wipe the injection site with the second alcohol pad and let it air-dry.
10. Pinch a fold of skin and insert the needle at a 90-degree angle (or 45 degrees if you have very little subcutaneous tissue). Push the plunger steadily.
11. Withdraw the needle and discard in a sharps container.

Total elapsed time, after a few weeks of practice: under two minutes.

Storage, shelf life, and travel

Refrigeration after reconstitution. Store the reconstituted vial between 36 and 46 degrees Fahrenheit (2 to 8 degrees Celsius). The body of the refrigerator works; the door has too much temperature variation. Don't store next to the freezer wall.

Shelf life. Most compounding pharmacies stamp 28 days from reconstitution when bacteriostatic water is used. Some specify 21 days. If sterile water (preservative-free) was used, the window drops to 7 to 14 days. Check the pharmacy's instruction sheet.

Don't freeze. Freezing causes ice crystal formation that damages the peptide structure. A frozen vial is no longer reliable, even if it thaws clear. Discard.

Travel. Use an insulated travel bag with a frozen gel pack (not direct ice contact). The medication should stay between 36 and 46 degrees Fahrenheit. Avoid airport X-ray machines if possible; while not definitively shown to harm peptides, the cumulative exposure across multiple flights could matter for shelf life. Carry the original prescription label and a letter from your provider for security. Many compounding pharmacies provide travel kits on request.

At room temperature. Tirzepatide can sit at room temperature for up to about 21 days after reconstitution, but cumulative exposure across the 28-day vial life adds up. The conservative practice is to refrigerate continuously, taking the vial out only for the 15-minute pre-warming before injection.

Common mistakes and how to spot them

The four most common reconstitution errors patients report.

Mistake 1: Adding the wrong volume of water. Adding 1 mL when the instruction said 1.5 mL changes the concentration from 10 mg/mL to 15 mg/mL. The same "25 units" now delivers 3.75 mg instead of 2.5 mg. The fix: read the instruction sheet, not a generic guide, and use a 3 mL syringe with clear graduations to measure water volume.

Mistake 2: Shaking the vial too hard. Foam in the vial after reconstitution suggests excessive agitation. The peptide can denature at the air-liquid interface inside foam bubbles. The fix: gentle swirling only. If your vial foamed, set it in the refrigerator for 30 to 60 minutes and the foam usually settles. The dose is probably still effective but slightly degraded.

Mistake 3: Drawing through a foam layer. If you see foam on top of the solution and you draw from the top, you'll get less than the intended dose. The fix: tip the vial slightly and aim the needle below any foam layer.

Mistake 4: Not labeling the vial. "I think I reconstituted this on the 12th. Or maybe the 5th." After 28 days, the vial should be discarded. Without a date, you can't be confident. The fix: write the date on the cap with a permanent marker the moment you finish reconstitution.

When to discard a vial

Discard the reconstituted vial in any of the following situations:

• More than 28 days since reconstitution (or 14 days if sterile water was used)
• Cloudiness, particulate matter, or visible aggregates after sitting refrigerated
• Discoloration outside clear-to-faint-straw-yellow (a pink or red tint usually means added vitamin B12, but verify with your pharmacy)
• The vial was accidentally frozen
• The vial sat at room temperature for more than 24 hours uninterrupted
• The rubber stopper shows damage or has been punctured more than the manufacturer's stated maximum (typically 28 to 30 punctures)

Discard the vial in a sharps container if you have one, or per your local hazardous waste rules. Don't pour the contents down the drain.

For more on what to look for in a compounded vial, see our guide on related guide.

FAQ

How much bacteriostatic water do I add to a 15 mg tirzepatide vial?

The most common is 1.5 mL, which yields a 10 mg/mL solution. Some pharmacies use 0.75 mL (for 20 mg/mL) or 3 mL (for 5 mg/mL). Always follow your specific pharmacy's instructions.

How many doses does a 15 mg vial give me?

At 2.5 mg per week, 6 doses. At 5 mg per week, 3 doses. At 7.5 mg per week, 2 doses. At 10 mg per week, 1.5 doses (and you'll discard the remainder). At 15 mg per week, 1 dose.

Can I shake the vial to mix it faster?

No. Shaking creates foam, and the air-liquid interface in foam bubbles can damage the peptide. Swirl gently for 30 to 60 seconds. If powder remains, let it sit and swirl again.

What does the reconstituted solution look like?

Clear and colorless, sometimes a faint straw yellow. If you see cloudiness, particles, or discoloration outside that range, contact your pharmacy.

How long is the vial good for after reconstitution?

28 days when reconstituted with bacteriostatic water and refrigerated continuously. Shorter (7 to 14 days) if sterile water was used.

Can I leave the vial at room temperature?

Briefly, yes. The medication is stable at room temperature for short periods, but cumulative exposure adds up. The conservative practice is continuous refrigeration with a 15-minute room-temperature warm-up before injection.

What if I add too much water by accident?

The concentration drops, so you'll need to draw more units to get the same dose. Recalculate using the new concentration. If you're not confident, call the pharmacy before injecting.

What if I add too little water?

The concentration rises, so the same unit count delivers a higher dose. Stop, don't inject, and call the pharmacy. Adding more water to a partially-mixed vial can create a measurement problem because some powder may have already dissolved.

Can I reuse the bacteriostatic water vial for the next reconstitution?

Yes, if the bacteriostatic water vial is multi-dose (most are 30 mL) and within its shelf life after first puncture (typically 28 days). Wipe the stopper with a fresh alcohol pad each time.

Do I need a prescription for bacteriostatic water?

Compounding pharmacies typically dispense bacteriostatic water alongside the lyophilized tirzepatide vial. If you need to source it separately, it usually requires a prescription.

Can I split a 15 mg vial across two patients?

No. Compounded medications are dispensed for a single patient based on an individual prescription. Sharing the vial creates infection control and legal issues.

What syringe size should I use to draw weekly doses?

A U-100 insulin syringe with a 0.3 mL or 0.5 mL barrel and a 31-gauge, 5/16-inch needle is standard. The 0.3 mL barrel has half-unit markings, which helps with fractional doses.

Should the powder dissolve completely?

Yes. After 30 to 60 seconds of gentle swirling, the solution should be uniformly clear with no visible powder. If powder remains, swirl gently again. If it still won't dissolve after 5 minutes, contact the pharmacy.

Author / review note

Reviewed by the FormBlends Medical Team. References include the U.S. Pharmacopeia chapter on compounded sterile preparations (USP <797>), the FDA guidance on compounded drug products (2024), and the SURMOUNT-1 trial publication (Jastreboff et al., New England Journal of Medicine, 2022). Reconstitution volumes follow standard compounding pharmacy practice and may vary by individual prescription.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.